Cambridge Glycoscience
- Founded in: 2017
- Number of employees: 2
- Country: United Kingdom
- Investors: Y Combinator, Felicis Ventures, Global Founders Capital, Romulus Capital, DCVC, Western Technology Investments
- Market: Sugar in the manufactured food industry
- Website: camglyco.com
Which input provides your business model/core technology towards a bio-based economy?
Our sugar substitutes are made using cheap and abundant plant material. This means that they can be sustainably produced, contributing towards a bio-based economy.
Which market/clients do you address and which short-term/long-term goals do you have?
We address all businesses aiming to reduce the sugar content of their food products, with an initial focus on bakery segments. In the short-term, we aim to sell to restaurants. In the long-term, our goal is to supply multinational food manufacturing companies to enable sugar reduction in mainstream food products.
What makes your approach unique compared to other stakeholders in the field?
Current bulking sweeteners are more expensive than sugar on a weight-per-weight bases. Our sugar substitutes are forecast to meet cost parity with sugar at scale, removing the economic barrier to reducing sugar in mainstream food products.
You can meet Cambridge Glycoscience in Toulouse at the START-UP VILLAGE @EFIB on 17-18 October.